In experimental studies, it has been found that certain cell lines are more sensitive to low-dose radiation than its expected by the classical linear-quadratic model (LQ model). In fact, it is frequently observed that cells incur more damage at low doses (say 0.3 Gy) than at higher dose (say 1 Gy). This effect has been termed hyper-radiosensitivity (HRS) and increased radio-resistance (IRR). The effect depends on the type of cells and on their state inside the cell-cycle. Here we design and analyze a differential equation model for the cell cycle that includes G2-checkpoint dynamics and radiation treatment. We fit the model to surviving data for different cell lines including glioma cells, prostate cancer cells, as well as to cell populations that are enriched in certain cell-cycle phases. The HRS/IRR effect is measured in the literature through a ratio $\alpha_s/\alpha$ of the slope $\alpha_s$ of the surviving curve at zero dose versus the slope $\alpha$ of the corresponding LQ model. Using our model we were able to derive an explicit formula for this ratio and we can show that it corresponds very closely to experimental observations. Finally, we can identify the dependence of this ratio on the surviving fraction at 2 Gy. It was speculated in the literature that such a relation exists. Our theoretical analysis will help to more systematically identify the HRS/IRR in cell lines and opens doors to analyze its use in cancer treatment.
